Mevaldi B.V. successfully secures funding from High-Tech Gründerfonds and ICIG Ventures to scale its innovative biobased technology, aimed at transforming the European chemical industry towards sustainability.
Information on the Target
Mevaldi B.V., a pioneering biotech company based in the Netherlands, specializes in biobased building blocks for sustainable polymers and polyurethanes derived from natural, biological raw materials. Founded in 2020, Mevaldi has been focusing on the development of 3MPD, an innovative biobased component designed for high-performance applications in coatings, adhesives, and elastomers. Unlike fossil-derived alternatives, 3MPD is produced from renewable resources utilizing a patented hybrid bio-thermochemical process. This enables the use of materials such as sugar for sneaker soles and sawdust as insulation in residential construction.
Mevaldi's approach results in a unique combination of high-quality material properties, reduced environmental impact, and competitive pricing, with the entire production chain occurring within Europe. The company leverages the existing flexible fermentation and chemical facilities of the International Chemical Investors Group (ICIG), minimizing dependence on supply chains from other global regions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The biotech sector in the Netherlands is one of the leading industries in Europe, characterized by high levels of innovation and investment. The country has established a robust infrastructure for supporting startups and scale-ups in various biotech field
Similar Deals
High-Tech Gründerfonds (HTGF) and ICIG Ventures
invested in
Mevaldi B.V.
in 2020
in a Other VC deal